Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-05-13 15:00:18
Reporting Period:
Accepted Time:
2019-05-13 15:00:18
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
788920 Pro Dex Inc PDEX Surgical & Medical Instruments & Apparatus (3841) 000000000
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1058465 Farnam Street Partners Lp /mn 3033 Excelsior Boulevard
Minneapolis MN 55416
No No Yes No
1361476 E Raymond Cabillot 3033 Excelsior Boulevard
Ste. 560
Minneapolis MN 55416
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-05-09 3,912 $17.67 425,111 No 4 S Indirect By Farnam Street Partners, L.P
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Farnam Street Partners, L.P
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting persons on December 4, 2018.
  2. The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.50 to $17.76, inclusive. The reporting person undertakes to provide Pro-Dex, Inc., any security holder of Pro-Dex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form.